About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
163
By Phase
PHASE1/PHASE2: 2PHASE1: 1
By Status
NOT_YET_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06931990Lead Sponsor
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
PHASE1/PHASE2Not yet recruiting
24 participants
Started: Apr 15, 2025 · Completed: Dec 30, 2025
NCT06932003Lead Sponsor
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
PHASE1/PHASE2Not yet recruiting
12 participants
Started: Apr 15, 2025 · Completed: Dec 30, 2025
NCT06082323Lead Sponsor
A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
PHASE1Recruiting
127 participants
Started: Jun 13, 2024 · Completed: Jun 1, 2025
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...